Orion Capital Management »

Halozyme Therapeutics shares owned by Orion Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Orion Capital Management from 13F filings

Historical chart of Orion Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Orion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Orion Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $282k 3.9k 73.34
2025-06-30 $10k 200 52.02
2024-12-31 $9.6k 200 47.81

More positions owned by Orion Capital Management

Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr Core S&p500etf (IVV)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
American Centy Etf Tr Us Eqt Etf (AVUS)
Apple (AAPL)
Etf Ser Solutions Distillate Us (DSTL)
Vanguard Specialized Funds Div App Etf (VIG)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Invesco Exchange Traded Fd T S&p500eql Wgt (RSP)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
NVIDIA Corporation (NVDA)
Intuitive Surgical Com New (ISRG)
American Centy Etf Tr Intl Eqt Etf (AVDE)

View all positions for Orion Capital Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Arrowstreet Capital, Limited Partnership
Invesco
UBS Group
Snyder Capital Management
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Alliancebernstein
Morgan Stanley
Macquarie Group
Federated Investors
Congress Asset Management

View all funds holding Halozyme Therapeutics